tiprankstipranks
Trending News
More News >
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
US Market
Advertisement

Akero Therapeutics (AKRO) Ownership - Who Owns Akero Therapeutics?

Compare
599 Followers

Akero Therapeutics (AKRO) Ownership Overview

3.39%25.05%<0.01%12.83%58.72%
<0.01% Other Institutional Investors
12.83% ETFs
58.72% Public Companies and Individual Investors
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail, and individual investors. Approximately 37.89% of the company’s stock is owned by Institutional Investors, 3.39% is owned by Insiders, and 58.72% is owned by Public Companies and Individual Investors.
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail, and individual investors. Approximately 25.06% of the company’s stock is owned by Institutional Investors, 3.39% is owned by Insiders, and 12.83% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 20, 2025
xxxxxxxxxxxxx
$363041
Jun 20, 2025
xxxxxxxxxxxxx
$61914
Jun 20, 2025
xxxxxxxxxxxxx
$47766
Jun 20, 2025
xxxxxxxxxxxxx
$89554

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$19460193
Mar 31, 2025
xxxxxxxxxxxxx
$22211902
Mar 31, 2025
xxxxxxxxxxxxx
$32099020

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,288,311Institution5.38%232,983,937
3,657,502Institution4.59%198,712,084
3,368,604Institution4.23%183,016,255
3,107,555Institution3.90%168,833,463
2,149,157Institution2.70%116,763,700
1,810,534Institution2.27%98,366,312
1,243,181Institution1.56%67,542,024
1,216,836Institution1.53%66,110,700
1,211,566Insider1.52%65,824,381
842,996Institution1.06%45,799,973

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,657,502Institution4.59%198,712,084
3,368,604Institution4.23%183,016,255
2,149,157Institution2.70%116,763,700
1,810,534Institution2.27%98,366,312
1,243,181Institution1.56%67,542,024
842,996Institution1.06%45,799,973
687,900Institution0.86%37,373,607
687,120Institution0.86%37,331,230
485,948Institution0.61%26,401,555
443,784Institution0.56%24,110,785

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,461,960Institution3.09%131,370,186
1,738,949Institution2.18%94,477,099
1,133,091Institution1.42%60,461,736
1,082,727Institution1.36%58,034,167
622,756Institution0.78%33,834,333
441,066Institution0.55%23,963,116
355,934Institution0.45%18,992,638
345,633Institution0.43%18,525,929
173,336Institution0.22%9,249,209
145,609Institution0.18%7,910,937

FAQ

Who Owns Akero Therapeutics Inc (AKRO)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 3.39% is held by insiders, and 58.72% is held by retail investors.
    What percentage of Akero Therapeutics Inc (AKRO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Akero Therapeutics Inc (AKRO) stock is held by institutional investors.
      What percentage of Akero Therapeutics Inc (AKRO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 58.72% of Akero Therapeutics Inc (AKRO) stock is held by retail investors.
        Who owns the most shares of Akero Therapeutics Inc (AKRO)?
        Vanguard owns the most shares of Akero Therapeutics Inc (AKRO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis